News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Ramesh Raju Mavuleti

Ramesh Raju Mavuleti*, rrajum@gmail.com, is head of operations, Validation Services India, at Merck Life Sciences Pvt, Ltd.

Articles by Ramesh Raju Mavuleti

Close-up of tubes in Brookhaven National Laboratory | Image Credit: © Bill Gallery - © Bill Gallery - stock.adobe.com

Application of the Risk Evaluation Matrix as per USP <665> and <1665> for Evaluation of Leachables Risk from Single-Use Components Used in Biomanufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee ,Somasundaram Gopalakrishnan,Tathagata Ray

June 6th 2024

Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.

bag of medical serum | Image Credit: © mailsonpignata - © mailsonpignata- Stock.adobe.com

Review of SUT Adoption in Biopharma Manufacturing

ByRamesh Raju Mavuleti,K. Vasantakumar Pa,K. Sreedhara Ranganath Pai,Subhasis Banerjee,Somasundaram Gopalakrishnan,Tathagata Ray

March 15th 2024

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Latest Updated Articles

Review of SUT Adoption in Biopharma Manufacturing
Published: March 15th 2024 | Updated:
Application of the Risk Evaluation Matrix as per USP <665> and <1665> for Evaluation of Leachables Risk from Single-Use Components Used in Biomanufacturing
Published: June 6th 2024 | Updated:

Trending on BioPharm International

Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential

Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas

AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D

Welcome to CPHI Frankfurt 2025

Regulatory Challenges for Global Manufacturing of Vaccines

© 2025 MJH Life Sciences^®

All rights reserved.